Dealmakers newsletter: February 2008
Welcome to February's edition of the Dealmakers newsletter from CurrentPartnering.
Sponsored by: Intralinks | Verticali | EuroPLX | DMS Data Systems
If not already signed up to receive our newsletters, do so here.
In this issue:
- Editor's corner
- New partnering reports
- In the news - January 2008
- New best practice articles
- Forthcoming events
- Scorecards - updated
- People on the move
- Partnering resources: Online partnering
The February issue of Dealmakers is sponsored by:
BioBusiness 2008 is the industry’s most exclusive senior bio-partnering event, taking place at the Intercontinental Geneva from 26th-28th February 2008. With critical insight into therapeutic areas and business development issues backing up an agenda geared to facilitate intensive networking, people who want to do serious business will attend BioBusiness 2008.
For more information on our in-depth, expert led agenda and the excellent one-to-one meeting opportunities available, please log on to http://www.wbr.co.uk/biobuiness08 or email us at biobusiness@wbr.co.uk.
EDITOR'S CORNER
Roche got 2008 off to a flying start when its offer to acquire Ventana being accepting after an improved bid, proving that persistence really can pay off.
Merger and acquisition is a powerful means of securing R&D and product assets as well as strategically shifting to meet new business challenges.
Whilst the mega merger seems to be out of fashion, acquisition of smaller biotechs by bigpharma is definitely in vogue.
Our latest report Merger and Acquisition Agreements in Biopharma explores the M&A agreement and recent trends in detail. It provides an excellent accompaniment ot out other recent report Co-promotion and co-marketing Agreements in Biopharma.
Until next time - happy dealmaking!
- Steve Poile
NEW PARTNERING REPORTS
Merger and Acquisition Agreements in Biopharma
The Merger and Acquisition Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies Merger and Acquisition Agreements in Biopharma
Co-promotion & Co-marketing Agreements in Biopharma
The Co-promotion and Co-marketing Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies Co-promotion & Co-marketing Agreements in Biopharma
Also:
Practical Guide to Finding Partners in Biopharma
CurrentPartnering’s Practical Guide to Finding Partners in Biopharma provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity Practical Guide to Finding Partners in Biopharma
IN THE NEWS
The latest partnering developments - January 2008:
- Sepracor acquires US rights to Nycomed's Alvesco HFA and Omnaris AQ plus ciclesonide pipeline
- TransTech acquires three programs for the treatment of metabolic disorder from Novo Nordisk
- MD Anderson Cancer Center and AstraZeneca in alliance to advance understanding of cancer
- BioSeek initiates drug discovery collaboration with Dainippon Sumitomo
- Teva to acquire CoGenesys for $400 million
- Exelixis and Bristol-Myers Squibb to co-develop XL139
- Novexel and Forest in license agreement for NXL 104
- Roche extends offer to acquire Ventana Medical Systems
- Pfizer in $250M tissue regeneration deal
NEW BEST PRACTICE ARTICLES
Partnering Event Best Practices - Part 3: Attending Effectively - And Harvesting, Too!
In the third and last part we will look at some prerequisites of an effective attendance that leads to partnering success. Unfortunately, some very important requirements for an effective attendance have to be met by the organiser and, therefore, are beyond the control of the delegate Partnering Event Best Practices - Part 3: Attending Effectively - And Harvesting, Too!
BioEurope Spring Continues Success of European Partnering Meetings
BIO-Europe Spring 2008, to be held in the Palacio Municipal de Congresos, Madrid, Spain, April 7-9, is expected to keep the highly productive partnering exchanges flowing between biotech and pharma BioEurope Spring Continues Success of European Partnering Meetings
Blog matters: What to do with Orphan IP?
"Orphan IP" is intellectual property which has not been commercialised. Usually relating to patents and know-how (confidential information) in the technology transfer area, it has been the subject of many and varied 'revolutionary' suggestions Blog matters: What to do with Orphan IP?
FORTHCOMING EVENTS
Here is our suggested partnering events for early 2008.
Global Biopharmaceutical Outsourcing
February 25-26, 2008, Philadelphia, PA, USA
This two day, intensive event covers the essential and vital information you need to keep your projects on track while minimizing costs Global Biopharmaceutical Outsourcing
BIO-Windhover 2008
March 16-18, 2008, The Grand Hyatt New York City, USA
Maximize your partnering hours. Making sure you see the right decision-makers at one meeting! BIO-Windhover 2008
Pharmaceutical Strategic Outlook 2008
March 18-20, 2008, The Grand Hyatt New York City, USA
Windhover’s must-attend event examines and explains the most important strategic alliances of the last year, and looks ahead to what the industry can expect in the upcoming year Pharmaceutical Strategic Outlook
BioEurope Spring 2008
April 7-9, 2008, Madrid, Spain
The BIO-Europe Spring™ event is the premier springtime partnering conference for the biotechnology industry. The inaugural event held in Milan, Italy in March 2007 brought together 1,200 executives representing biotechnology, pharmaceutical and finance companies from 35 countries around the world.
Over a three-day period, delegates engaged in more than 4,000 individual partnering meetings to identify new business opportunities and develop strategic relationships that accelerate their business. The event features the successful combination of one-to-one partnering meetings and company presentations; characteristic of all EBD’s partnering events BioEurope Spring 2008
Fifth Annual Alliance Management Congress
April 9-11, 2008, Philadelphia, PA, USA
The most prominent alliance management event in North America Alliance Management Congress
SCORECARDS
Our scorecards are updated with the latest deals to break into our most valuable deal rankings - the largest deal for 2008 is Genzyme-Isis in a $1,900M cardiovascular deal. Plus there is the top M&A deal of the year so far between Roche and Ventana.
- Partnering Top 20 - 2008
- Partnering Top 20 - 2007
- Partnering since 2000
- M&A Top 20 - 2008
- M&A Top 20 - 2007
- M&A since 2000
- Bigpharma Top 25 partnering - 2007
PEOPLE ON THE MOVE
The following people have been reported on the move during the first weeks of 2008:
Susan Barker, Rick Schindewolf, Matthew Walker, Wendy Perrow, Rohan Palekar, Maria Dzaleta, Steven Sembler, Steven Ritter, Robert Mattioli, Jane Pritchett Henderson, John Riesenberger, Tom D'Orazio, Matthew Meyer, John Wulf, to name just a few
read more about the latest people on the move
If you have news about a business development executive who is on the move - let us know
PARTNERING RESOURCES: ONLINE PARTNERING
Numerous websites exist that cater for start-ups, corporations, universities and federal labs to promote their technologies available for partnering or financing - online partnering
Do you use online partnering websites? Do they offer real benefits? Give us your opinions about Online Partnering here
CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers
Advertizing and sponsorship
CurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online.
or contact us to discuss your requirements.
Steve Poile, Editor
Web: http://www.CurrentPartnering.com
Mail: Current Partnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom
Tel: +44 7896 656732
Fax: +44 8703 305993
Scorecard Index
Deal term reports
The information you provide is excellent and we look forward to doing more business with you in the future
...You have published very timely and interesting materials.... I am excited.... It is an excellent publication and pretty well up to date...
CurrentPartnering Reports
The latest reports on best practise for dealmakers available from CurrentPartnering
Quick links
Term of the week...
Heads of agreement A pre-agreed document that outlines the key elements and structure of the planned deal.